Dopamine receptors in rat frontal cortex: pharmacological properties in vivo and in vitro.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D001058:Apomorphine / Q000378:metabolism; D001667:Binding, Competitive; D002069:Butaclamol / Q000494:pharmacology; D002421:Caudate Nucleus / Q000378:metabolism*; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism*; D002746:Chlorpromazine / Q000494:pharmacology; D003024:Clozapine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006719:Homovanillic Acid / Q000378:metabolism; D007700:Kinetics; D008297:Male; D010868:Pimozide / Q000494:pharmacology; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism*; D013134:Spiperone / Q000378:metabolism / Q000494:pharmacology; D013881:Thioridazine / Q000494:pharmacology
D011954:Receptors, Dopamine; D015102:3,4-Dihydroxyphenylacetic Acid; D010868:Pimozide; D013134:Spiperone; D002069:Butaclamol; D003024:Clozapine; D006220:Haloperidol; D001058:Apomorphine; D013881:Thioridazine; D002746:Chlorpromazine; D006719:Homovanillic Acid